• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Modified Biological Molecule Market

Modified Biological Molecule Market segmentation on basis of product type (Pharmaceutical and non-pharmaceutical), by application (healthcare, agriculture, food and beverages, and others), by end user (Biochemical industry, Research laboratories and academic institutes, Biotechnology industry, pharmaceutical industry and others)


Market Synopsis:

Modified biological molecule is the joining of DNA molecules together from two different species and then is inserted into a host organism so as to produce a new genetic modified combination that adds value to healthcare and agriculture industry. Mostly used genetically modified products in healthcare are vaccines, monoclonal antibodies, and insulin, which have a huge market in the pharmaceutical industry. Enzyme production and recombinant proteins are mainly used in industrial purpose. National Academy of Medicine and National Academy of Sciences have taken initiative for involving new research in human gene-editing technique that will lead to the rising new treatment for the disorder.

Cipla and Roche have signed an agreement for sale and promotion of tocilizumab. The partnership will be beneficial to increase innovation and improve healthcare facilities. Recombinant Human growth hormone (hGH) was found to be of great progress in treating children. Various application of modified biological molecule in medicine is that it is used for gene therapy, synthesizing clotting factors, vaccination, and antiviral therapy. In agriculture, it is used for pesticide resistant crops, to grow genetically modified crops, to grow fruits with attractive colors (all this has been grown in artificial conditions). In pharmacology, it is used to produce artificial insulin, drug delivery at various targeted sites. Also, other applications of modified biological molecule market are to produce fluorescent fishes and glowing plants. The strategies for the treatment of various disorders are also improving by developing monitoring devices, diagnostic kits and new approaches in therapeutics. Large numbers of recombinant proteins are being used as an enzyme in various industries. Some of the major proteins used are proteins that are present in milk, and polymeric proteins are used in medical field and industries.

The major factor that fuels the growth of Modified biological molecule market is the increasing need to improve recombinant proteins. Recombinant proteins are the proteins that result in expression of recombinant DNA in living cells.  This recombinant protein produces several folds that increase the demand for effective therapeutics for the treatment of disease. Also, various driving factors that grow the market are increasing use of genetically modified organisms, which are widely used in agriculture and this is one of the fastest and adopted innovations in last few years. Also, raising the burden of various chronic disorders and commercial success of biopharmaceutical industry are boosting the growth of this market. On the other hand, a high investment that is needed to establish manufacturing facilities of recombinant DNA, high complexity in producing recombinant DNA and adoption of genetically modified crops is less in developing countries which hamper the growth of the market.

Business Intelligence:
The University of Pennsylvania has received approval from National Institutes of Health and the FDA in January 2018 to conduct first CRISPR trial to treat multiple myeloma, sarcoma and melanoma patients in U.S. University of Iowa and Columbia University Medical Center (CUMC) have used CRISPR for  the retinitis pigmentosa (RP) to repair genetic mutation in 2016. There are 1.5 million cases of retinitis pigmentosa worldwide that affects retina to degrade and that leads to blindness. Sanofi Pasteur acquired Protein Sciences in 2017 with a strategy to add Flublok vaccine to its portfolio which is the recombinant protein-based vaccine approved by U.S. Food and Drug Administration.
This report provides analysis of modified biological molecule market that contains current industry trends, market size, market growth and demands, major players with their key strategies. It covers growth opportunities and market canvas in the coming years. The report has been made with an in-depth analysis along with inputs from the various industry experts. The research has been carried out with primary and secondary data sources and either supporting bottom-up or top-down approach.

Regional Analysis:
Based on region, the global modified biological molecule market is segmented into North America, Europe, Asia-Pacific, and LAMEA. Regulatory structure of genetically engineered crops is improving in Japan. Soya and corn are majorly cultivated among other genetically modified crops in the U.S.

Major Players:
Some of the major players are Merck & Co., Pfizer Inc, Profacgen, GenScript, F. Hoffmann-La Roche Ltd, Novo Nordisk A/S, Sanofi, Eli Lilly and Company, and Amgen Inc

Global Composite Testing Market Segmentation:
By Product

• Pharmaceutical
o Recombinant protein
o Therapeutics agents
o Vaccines
• Non- Pharmaceutical
o Biochemical 
o Genetically modified crop
o Others
By Application
• Healthcare
• Agriculture
• Food and beverages
• Others
By End User
• Biochemical industry
• Research laboratories and academic institutes
• Biotechnology and pharmaceutical industry 
• Others
Regions covered
• North America (U.S and Canada and rest of North America)
• Europe (Germany, France, Italy and Rest of Europe)
• Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific)
• LAMEA (Brazil, Turkey, Saudi Arabia, South Africa and Rest of LAMEA)


									

	

Related Reports

North America Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

North America trauma fixation market is projected to register a healthy CAGR of 7.0 % in the forecast period of 2018 to 2025. The new market report contains data for historic years 2017, the base year ...read more

Middle East and Africa Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Middle East & Africa trauma fixation market is projected to register a healthy CAGR of 5.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2017, the base y ...read more

Global Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Global trauma fixation market is projected to register a healthy CAGR of 6.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2017, the base year of calcula ...read more

Europe Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Europe trauma fixation market is projected to register a healthy CAGR of 6.5 % in the forecast period 2018 to 2025. The new market report contains data for historic years 2017, the base year of calcul ...read more

Asia-Pacific Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Asia Pacific trauma fixation market is projected to register a healthy CAGR of 7.5 % in the forecast period 2018 to 2025. The new market report contains data for historic years 2017, the base year of ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.